-+ 0.00%
-+ 0.00%
-+ 0.00%

Oriental Biotech said at the 2026 semi-annual online performance briefing held on September 10 that the company has developed high-quality Ebola antigen tests and nucleic acid detection reagents, and has laid out detection reagents for other insect-borne diseases, and the related market is expanding. In addition, the company's quantum dot flow fluorescence equipment and reagents have obtained many domestic and foreign certificates, gradually industrialized and entered domestic and foreign markets, and the market feedback is good.

Zhitongcaijing·09/10/2026 04:17:05
Listen to the news
Oriental Biotech said at the 2026 semi-annual online performance briefing held on September 10 that the company has developed high-quality Ebola antigen tests and nucleic acid detection reagents, and has laid out detection reagents for other insect-borne diseases, and the related market is expanding. In addition, the company's quantum dot flow fluorescence equipment and reagents have obtained many domestic and foreign certificates, gradually industrialized and entered domestic and foreign markets, and the market feedback is good.